Stocktoria
iRhythm Holdings, Inc. IRTC
iRhythm Holdings, Inc. (IRTC) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $747.1M at a -6.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.04 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-22 | BTIG | Buy (reit) |
| 2026-06-10 | BTIG | Buy (reit) |
| 2026-06-01 | Canaccord Genuity | Buy (main) |
| 2026-05-18 | B of A Securities | Buy (main) |
| 2026-05-04 | Citigroup | Buy (main) |
| 2026-05-01 | Canaccord Genuity | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.54 |
| Retained earnings / assets | -0.788 |
| EBIT / assets | -0.056 |
| Equity / liabilities | 0.176 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| IRTC | iRhythm Holdings, Inc. | 5/9 | 0.78 | — | +26.2% |
| ATEC | Alphatec Holdings, Inc. | 6/9 | -4.63 | — | +25% |
| OFIX | Orthofix Medical Inc. | 5/9 | 1.02 | — | +2.9% |
| NVCR | NovoCure Ltd | 3/9 | -2.29 | — | +8.3% |
| UFPT | UFP TECHNOLOGIES INC | 7/9 | 6 | 28.7 | +19.5% |
| INSP | Inspire Medical Systems, Inc. | 6/9 | 9.88 | 9.1 | +13.6% |
| BVS | Bioventus Inc. | 8/9 | 0.54 | 35.9 | -0.9% |
About iRhythm Holdings, Inc.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
FAQ
Is IRTC financially healthy?
iRhythm Holdings, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does IRTC pay a dividend?
No, iRhythm Holdings, Inc. does not currently pay a dividend.
How profitable is IRTC?
In FY2025, iRhythm Holdings, Inc. had a net margin of -6.0% and a return on equity of -29.2%.
What is the analyst price target for IRTC?
The average Wall-Street price target for iRhythm Holdings, Inc. is $178.93, about 42.7% above the recent price, from 14 analysts (consensus: strong buy).
Is IRTC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on iRhythm Holdings, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.